---
figid: PMC6334777__nihms-1001994-f0004
figlink: /pmc/articles/PMC6334777/figure/F4/
number: F4
caption: As shown in Panel A, canonical MAPK signaling transduces extracellular signal
  through receptor tyrosine kinase (RTK), which activates Ras, then RAF, then MEK,
  and then extracellular signal-regulated kinase (ERK) proteins, which in turn regulate
  cell-specific nuclear targets and gene transcription programs. Activating mutations
  such as BRAF V600E drive constitutive ERK activation and downstream transcriptional
  targets, including BCL2L1 (up-regulated) and CCR7 (down-regulated). The pie chart
  in Panel B shows the proportions of cases with specific activating MAPK mutations
  in a primarily pediatric series from one center.
pmcid: PMC6334777
papertitle: Langerhans-Cell Histiocytosis.
reftext: Carl E. Allen, et al. N Engl J Med. 2018 Aug 30;379(9):856-868.
pmc_ranked_result_index: '113468'
pathway_score: 0.6064939
filename: nihms-1001994-f0004.jpg
figtitle: Activating MAPK Pathway Mutations in LCH
year: '2018'
organisms:
- Mus musculus
- Osphranter robustus
- Homo sapiens
ndex: da355380-df35-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6334777__nihms-1001994-f0004.html
  '@type': Dataset
  description: As shown in Panel A, canonical MAPK signaling transduces extracellular
    signal through receptor tyrosine kinase (RTK), which activates Ras, then RAF,
    then MEK, and then extracellular signal-regulated kinase (ERK) proteins, which
    in turn regulate cell-specific nuclear targets and gene transcription programs.
    Activating mutations such as BRAF V600E drive constitutive ERK activation and
    downstream transcriptional targets, including BCL2L1 (up-regulated) and CCR7 (down-regulated).
    The pie chart in Panel B shows the proportions of cases with specific activating
    MAPK mutations in a primarily pediatric series from one center.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - MAPK3
  - MAP2K2
  - ARAF
  - KRAS
  - NRAS
  - ERBB3
  - MAPK1
  - BCL2L1
  - CCR7
  - BRAF
  - HRAS
  - RAF1
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: MAP2K1
  symbol: MAP2K1
  source: hgnc_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ARAF
  symbol: ARAF
  source: hgnc_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERBB3
  symbol: ERBB3
  source: hgnc_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: BCL2L1
  symbol: BCL2L1
  source: hgnc_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: CCR7
  symbol: CCR7
  source: hgnc_symbol
  hgnc_symbol: CCR7
  entrez: '1236'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
chemicals:
- word: Tyrosine
  source: ''
  identifier: ''
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6334777__F4
redirect_from: /figures/PMC6334777__F4
figtype: Figure
---
